Frameworks for targeting RNA with small molecules.

Area of Science:

• Molecular Biology
• Drug Discovery
• Biochemistry

Background:

• RNA molecules perform diverse cellular functions beyond protein synthesis, acting as direct effectors through ligand binding.
• Dysregulation of RNA is linked to diseases, making RNA a growing target for therapeutic development, complementing protein-targeting drugs.
• Small-molecule drugs are increasingly favored for RNA targeting due to advantages like oral bioavailability over oligonucleotide-based therapies.

Purpose of the Study:

• To review dominant frameworks for discovering small-molecule ligands targeting RNA.
• To analyze the strengths and weaknesses of existing RNA ligand discovery approaches.
• To propose an improved paradigm for RNA-targeting drug discovery.

Main Methods:

• Literature review of existing frameworks for RNA ligand discovery.
• Analysis of the merits and limitations of each framework.
• Synthesis of findings to propose a new strategic direction.

Main Results:

• Three primary frameworks for small-molecule RNA ligand discovery have been identified.
• Each framework presents unique advantages but also potential pitfalls if pursued exclusively.
• An integrated approach considering RNA structural subclasses is proposed.

Conclusions:

• RNA ligand discovery benefits from understanding diverse frameworks.
• Moving beyond single frameworks towards a subclass-based approach can enhance drug discovery.
• A paradigm shift focusing on RNA structural subclasses will advance RNA-targeting therapeutics.